GO
Loading...

Acorda 'firmly on the side of research': CEO

Thursday, 10 Jul 2014 | 8:43 AM ET

Ron Cohen, Acorda Therapeutics CEO, discusses merger activity in the pharma sector and whether his company is planning an acquisition.